- Home
- BQ vs BFRI Comparison
BQ vs BFRI Comparison
Compare BQ & BFRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BQ
- BFRI
- Stock Information
- Founded
- BQ 2008
- BFRI 1997
- Country
- BQ China
- BFRI United States
- Employees
- BQ N/A
- BFRI N/A
- Industry
- BQ Other Specialty Stores
- BFRI Biotechnology: Pharmaceutical Preparations
- Sector
- BQ Consumer Discretionary
- BFRI Health Care
- Exchange
- BQ Nasdaq
- BFRI Nasdaq
- Market Cap
- BQ 7.1M
- BFRI 7.9M
- IPO Year
- BQ 2020
- BFRI 2021
- Fundamental
- Price
- BQ $3.30
- BFRI $0.85
- Analyst Decision
- BQ
- BFRI Strong Buy
- Analyst Count
- BQ 0
- BFRI 1
- Target Price
- BQ N/A
- BFRI $2.75
- AVG Volume (30 Days)
- BQ 39.8K
- BFRI 377.9K
- Earning Date
- BQ 10-28-2025
- BFRI 11-12-2025
- Dividend Yield
- BQ N/A
- BFRI N/A
- EPS Growth
- BQ N/A
- BFRI N/A
- EPS
- BQ N/A
- BFRI N/A
- Revenue
- BQ $64,617,102.00
- BFRI $39,188,000.00
- Revenue This Year
- BQ N/A
- BFRI $11.07
- Revenue Next Year
- BQ N/A
- BFRI $11.20
- P/E Ratio
- BQ N/A
- BFRI N/A
- Revenue Growth
- BQ N/A
- BFRI 11.20
- 52 Week Low
- BQ $1.62
- BFRI $0.54
- 52 Week High
- BQ $9.89
- BFRI $2.22
- Technical
- Relative Strength Index (RSI)
- BQ 57.55
- BFRI 46.48
- Support Level
- BQ $2.88
- BFRI $0.81
- Resistance Level
- BQ $3.86
- BFRI $0.90
- Average True Range (ATR)
- BQ 0.36
- BFRI 0.05
- MACD
- BQ 0.01
- BFRI 0.00
- Stochastic Oscillator
- BQ 52.94
- BFRI 40.32
About BQ Boqii Holding Limited representing
Boqii Holding Ltd operates in the business of selling pet products through online stores. The store provides pet foods, health products, pet grooming products, pet bathing products, pet toys, fish tank, aquatic fertilizer, temperature control equipment, oxygen pump and other related products. Also, the company sells its products through offline channels to pet stores and hospitals.
About BFRI Biofrontera Inc.
Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy. The Company's licensed products, which include Ameluz as well as the BF-RhodoLED and RhodoLED XL lamps (together, the RhodoLED Lamps), are used for the treatment of actinic keratoses (AKs), which are pre-cancerous skin lesions.